61.92000 EUR
0
0%
Last update Nov 26, 5:15 PM CET
Market closed
Day range
61.92000
61.92000
Previous close
61.92000
Open
61.92000
Access this stock data via API
Subscribe
BridgeBio Pharma Inc.
61.92
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 102.9M 94.3M 99.4M 5.0M
Cost of revenue 5.6M 3.1M 2.2M 1.8M
Gross profit 97.3M 91.1M 97.2M 3.2M
Operating expense
Research & development 96.2M 94.8M 95.0M 111.1M
Selling general and admin 117.3M 110.1M 90.7M 80.8M
Other operating expenses
Operating income -116.2M -113.8M -88.5M -188.7M
Non operating interest income
Income 5.3M 3.3M 4.6M 4.0M
Expense 41.0M 32.1M 35.9M 25.4M
Other income expense -7.0M -12.3M -24.8M -16.8M
Pretax income -159.0M -154.9M -144.6M -227.0M
Tax provision -1.3M 1.8M
Net income -157.7M -156.7M -144.6M -227.9M
Basic EPS -1.0 -0.9 -1.4
Diluted EPS -1.0 -0.9 -1.4
Basic average shares 162.4M 162.1M 161.5M
Diluted average shares 162.4M 162.1M 161.5M
EBITDA -123.2M -126.9M -89.0M -194.2M
Net income from continuing op. -157.7M -156.7M -144.6M -227.9M
Minority interests 1.9M 1.6M 1.9M 2.0M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 6 hours 51 minutes

01:08
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).